Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

Yi-Ran HU; Wei HUA; Han JIN; Min GU; Xiao-Han FAN; Hong-Xia NIU; Li-gang DING; Jing WANG; Shu ZHANG

doi:10.11909/j.issn.1671-5411.2019.03.015

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

DOI: 10.11909/j.issn.1671-5411.2019.03.015

Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center

Yi-Ran HU

Wei HUA

Han JIN

Min GU

Xiao-Han FAN

Hong-Xia NIU

Li-gang DING

Jing WANG

Shu ZHANG

Keywords：Cardiac resynchronization therapyHeart failureSuper-responderOptimal medical therapy

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 251-258 )

Journal of Geriatric Cardiology

SCICSCD

ISSN：1671-5411

Year, Vol.(Issue)：2019,16(3)